RECURRENT MEDULLOBLASTOMA
Clinical trials for RECURRENT MEDULLOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MEDULLOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT MEDULLOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
RNA vaccine trial offers new hope for recurrent brain cancer patients
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase trial tests a personalized RNA vaccine for people with recurrent medulloblastoma, a type of brain tumor. The vaccine is made from the patient's own tumor material and aims to train the immune system to fight the cancer. The study includes up to 24 participants ag…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 01, 2026 00:00 UTC
-
Could a vaccine help fight childhood brain cancer? new trial underway
Disease control Recruiting nowThis Phase 2 trial is testing a vaccine called PEP-CMV in 120 children and young adults with high-grade glioma, diffuse intrinsic pontine glioma (DIPG), or recurrent medulloblastoma. The vaccine targets a common virus (CMV) found in many brain tumors, aiming to boost the immune s…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Promising targeted therapy for tough brain cancers moves forward
Disease control Recruiting nowThis study is testing a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dos…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Immune cells engineered to hunt brain tumors in kids
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and young adults with medulloblastoma or similar brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack tumor cells, deliv…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Parental distress may undermine treatment in children with recurrent brain tumors
Knowledge-focused Recruiting nowThis study investigates whether the emotional distress of parents—such as depression, anxiety, or trauma—affects how well children with recurrent medulloblastoma follow their treatment plans. Researchers will follow 450 parent-child pairs across four hospitals, measuring parental…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC